Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel
LON:GENI

GENinCode Final Earnings Report

GENinCode logo
GBX 1.13 -0.12 (-9.36%)
As of 12:18 PM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 2.53
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Final
Date
6/4/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode (LON:GENI) Trading Down 11.6% - Should You Sell?
June 4 at 4:32 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30818792
GENinCode slumps after it reprices options
May 7, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-slumps-reprices-options-101000125.html
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel
June 4 at 1:00 AM  |  Porter & Company (Ad)
AIM Market Roundup: Phoenix Copper, Pipehawk, Genincode
February 25, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-phoenix-copper-170020859.html
GENinCode Raises £4.1m Following Completion of WRAP Retail Offer
January 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-raises-4-1m-following-completion-of-wrap-retail-offer?utm_source=marketbeat.com&utm_medium=referral
TRADING UPDATES: GENinCode to raise funds via placing and subscription
January 21, 2026  |  lse.co.ukhttps://www.lse.co.uk/news/trading-updates-genincode-to-raise-funds-via-placing-and-subscription-pey94ezuzlqzggl.html
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile
Earnings Tools